Demant is a Danish hearing healthcare group founded in 1904 that designs, manufactures and distributes hearing aids, diagnostic equipment and clinical services globally. The company operates through several recognised hearing-aid brands - Oticon, Bernafon, Sonic and Philips Hearing Solutions - alongside divisions producing professional audiological equipment and a network of hearing-care clinics. Products and solutions reach over 130 countries, supported by subsidiaries in more than 30 countries.
The group employs more than 26,000 people and generates annual revenue exceeding DKK 22 billion. It is listed on Nasdaq Copenhagen, where it ranks among the 25 most traded stocks. The William Demant Foundation holds the majority of shares, reflecting long-term governance focused on the company's mission rather than short-term returns.
Research and development is central to Demant's operations, anchored by the Eriksholm Research Centre. The company spans four core business segments: hearing aids, hearing devices including diagnostics, hearing-care clinic services, and supporting functions. This integrated model connects consumer products with professional equipment and direct clinical care, enabling the group to serve both individual patients and healthcare practitioners across the audiology sector.
